September 2022 Legislative & Regulatory Briefing; AMCP Submits Comments to Improve the Medicare Advantage Program; New Member Benefit! Regulatory NewsBREAKS; AMCP Joins Request for PREP Act Declaration for Pharmacist Prescribing of Monkeypox Treatments; Request for Information: Make Your Voice Heard; ICYMI: August 2022 Legislative and Regulatory Briefing Webinar.
Last week, nearly 50 experts in managed care convened for AMCP’s Partnership Forum: Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement.
Partnership Forum: This Partnership Forum identified opportunities to improve how value assessments are developed and applied to formulary decision-making and provide strategies and guidance on best practices to equip managed care pharmacists and other professionals when applying these tools to assess value and optimize patient care.
On August 30, AMCP provided comments to the Centers for Medicare and Medicaid Services (CMS) following the agency's request for feedback on ways to strengthen the Medicare Advantage program.
On August 19, AMCP joined a wide coalition of pharmacy organizations in calling on the Department of Health and Human Services to issue a PREP Act declaration that pharmacists, pharmacy students, and pharmacy technicians, as appropriate, can order and administer FDA authorized or approved monkeypox vaccines, testing, and therapeutics.
August 2022 Legislative & Regulatory Briefing; Congress Passes the Inflation Reduction Act of 2022; AMCP Releases the Value-Based Contracts Resource Center; HHS Requests Nominees for the Presidential Advisory Council on Combatting Antibiotic-Resistant Bacteria; Attend AMCP’s Legislative & Regulatory Briefing Webinar, Aug. 23.